InsiderClue
Stocks · Health care · Pharmaceutical Preparations

AGIOS PHARMACEUTICALS, INC.

AGIO Clue Score43
United States Fiscal year ends December CIK 0001439222 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

6
Insider
Date
Role
Action
Shares
Price
Amount
Christopher Bowden
5 Feb 2020
Chief Medical Officer
Exercised, kept
35,447
$35.16
$1.25M
Scott Biller
11 Jun 2019
Chief Scientific Officer
Exercised, kept
7,218
$2.34
$16.87K
Scott Biller
21 Dec 2018
Chief Scientific Officer
Exercised, kept
20,500
$2.34
$47.92K
David P Schenkein
10 Sep 2018
Chief Executive Officer
Exercised, kept
8,730
$31.64
$276.22K
David P Schenkein
5 Sep 2018
Chief Executive Officer
Exercised, kept
2,500
$31.64
$79.10K
David P Schenkein
5 Sep 2018
Chief Executive Officer
Exercised, kept
72,619
$2.34
$169.93K
Showing 250 of 423 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 484
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 47
Sales straight out of an exercise 250
Sales at will 107
Transactions with no price 0
Shares from compensation/vesting 2,824,750
Sales filed before the plan box existed 96
History held since 30 Jul 2013